Huons Co., Ltd. (KOSDAQ: 243070)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,400
-100 (-0.36%)
Dec 30, 2024, 9:00 AM KST
-28.65%
Market Cap 323.61B
Revenue (ttm) 588.83B
Net Income (ttm) 35.53B
Shares Out 11.81M
EPS (ttm) 2,821.09
PE Ratio 9.71
Forward PE n/a
Dividend 660.00 (2.41%)
Ex-Dividend Date n/a
Volume 13,596
Open 27,800
Previous Close 27,500
Day's Range 27,200 - 27,850
52-Week Range 21,800 - 40,350
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy... [Read more]

Industry Pharmaceutical Preparations
Founded 1965
Employees 912
Stock Exchange KOSDAQ
Ticker Symbol 243070
Full Company Profile

Financial Performance

In 2023, Huons's revenue was 552.01 billion, an increase of 12.11% compared to the previous year's 492.39 billion. Earnings were 50.47 billion, an increase of 124.88%.

Financial Statements

News

There is no news available yet.